Regulator or regulatory shield? The case for reforming Canada's Patented Medicine Prices Review Board

Rujun Zhang¹, Danielle Martin², C David Naylor²

• ¹Family and Community Medicine (Zhang), Women's College Hospital; Medical Affairs and Health System Solutions (Martin), Women's College Hospital; Department of Family and Community Medicine, and Institute of Health Policy, Management and Evaluation (Martin), University of Toronto; Department of Medicine and Institute of Health Policy, Management and Evaluation (Naylor), University of Toronto, Toronto, Ont. henryzhang7@gmail.com.+1